Jeffrey Robert Ajer Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey Robert Ajer.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey Robert Ajer. Jeffrey Robert Ajer is Director in NEKTAR THERAPEUTICS ($NKTR) and EVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Commercial Of in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN).

Jeffrey Robert Ajer in BIOMARIN PHARMACEUTICAL INC

Trading Symbol: BMRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Robert Ajer: EVP, Chief Commercial Officer, SVP, Chief Commercial Officer, SVP, Chief Commercial Of
Holdings: 58,250 shares
Current Value: $5,179,008
Latest Transaction: Apr 09 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeffrey Robert Ajer in BIOMARIN PHARMACEUTICAL INC

Sentiment: All, BMRN, NKTR

Page:   < prev 1 2

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM14.396258,9940
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM14.393,12544,9690
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM17.86841,5000
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS69.5513,026906,01014,88027.9 K to 14.9 K (-46.68 %)
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM21.519,192197,72027,90618.7 K to 27.9 K (+49.12 %)
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM14.393,75053,96318,71415 K to 18.7 K (+25.06 %)
Dec 11 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM17.86841,50014,96414.9 K to 15 K (+0.56 %)
Nov 05 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS63.16996,25314,88015 K to 14.9 K (-0.66 %)
Nov 05 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...GrantA27.91992,76314,97914.9 K to 15 K (+0.67 %)
Jun 04 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS58.3449328,76314,88015.4 K to 14.9 K (-3.21 %)
Jun 04 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Payment of ExerciseF62.7029718,62215,37315.7 K to 15.4 K (-1.90 %)
May 17 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseA67.8149,0003,322,69049,000
May 17 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...GrantA0.008,400015,6707.3 K to 15.7 K (+115.54 %)
May 14 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS69.261,24886,4317,2708.5 K to 7.3 K (-14.65 %)
May 14 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Payment of ExerciseF67.6875250,8958,5189.3 K to 8.5 K (-8.11 %)
May 10 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS66.0081153,5289,27010.1 K to 9.3 K (-8.04 %)
May 10 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Payment of ExerciseF65.3248931,94110,08110.6 K to 10.1 K (-4.63 %)
May 03 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS64.5279751,42010,57011.4 K to 10.6 K (-7.01 %)
May 03 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...GrantA23.2079718,49011,36710.6 K to 11.4 K (+7.54 %)
Apr 23 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM21.515,000107,55015,500
Apr 23 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS65.005,000325,00010,57015.6 K to 10.6 K (-32.11 %)
Apr 23 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM21.515,000107,55015,57010.6 K to 15.6 K (+47.30 %)
Mar 06 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM21.514,00086,04020,500
Mar 06 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS60.004,000240,00010,57014.6 K to 10.6 K (-27.45 %)
Mar 06 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM21.514,00086,04014,57010.6 K to 14.6 K (+37.84 %)
Jan 24 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM21.513,00064,53093,034
Jan 24 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS55.003,000165,00010,57013.6 K to 10.6 K (-22.11 %)
Jan 24 2013BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM21.513,00064,53013,57010.6 K to 13.6 K (+28.38 %)
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM21.512,50053,77596,034
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM17.8691616,36098,534
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...Option ExerciseM14.392,50035,97599,450
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyS48.315,916285,81710,5704.7 K to 10.6 K (+127.12 %)
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM21.512,50053,77516,48614 K to 16.5 K (+17.88 %)
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM17.8691616,36013,98613.1 K to 14 K (+7.01 %)
Nov 30 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...BuyM14.392,50035,97513,07010.6 K to 13.1 K (+23.65 %)
Nov 14 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...SellS48.1126512,75010,57010.8 K to 10.6 K (-2.45 %)
Nov 14 2012BMRNBIOMARIN PHARMACEU ...Ajer Jeffrey RobertSVP, Chief Commerci ...GrantA21.762655,76610,83510.6 K to 10.8 K (+2.51 %)

Page:   < prev 1 2

Contact us | Follow us on Twitter